Abstract
For more than two decades we have been refining advances in islet cell transplantation as a clinical therapy for patients suffering from type 1 diabetes. A great deal of effort has gone to making this a viable therapy for a broader range of patients with type 1 diabetes. Clinical results have progressively improved, demonstrating clinical outcomes on par with other organ transplants, specifically in terms of insulin independence, graft and patient survival. We are now at the point where islet cell transplantation, in the form of allotransplantation, has become accepted as a clinical therapy in adult patients affected by type 1 diabetes, in particular those suffering from severe hypoglycaemic unawareness. This chapter provides an overview on how this has been undertaken over the years to provide outcomes on par with other organ transplantation results. In particular this chapter focuses on the processes and facilities that are required to establish a clinical islet isolation and transplantation program. It also outlines the very important underpinning processes of selection of the organ donor for islet isolation, the processes of organ donor operation and preservation of the pancreas by various means and the ideal ways to best improve outcomes for human islet cell isolation. Providing these more optimal conditions we can underpin the isolation processes to provide islets for transplantation and as such a safe, effective and feasible therapeutic option for an increasing number of patients suffering from type 1 diabetes with severe hypoglycaemic unawareness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CIT:
-
Cold ischaemic time
- CMRL:
-
Connaught Medical Research Laboratories
- CS:
-
Celsior
- HTK:
-
Histidine-tryptophan-ketoglutarate
- IEQ:
-
Islet cell isolation, islet equivalent
- IEQ/g:
-
Islet equivalents per gram
- MTC:
-
Mixed treatment comparison
- QALY:
-
Quality-adjusted life years
- SPK:
-
Simultaneous pancreas and kidney
- T1D :
-
Type 1 diabetes
- UW:
-
University of Wisconsin solution
References
Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care. 2012;35(7):1436–45.
Radomski M, Zureikat A. Total pancreatectomy and islet cell autotransplantation: outcomes, controversies and new techniques. JOP. 2015;16(1):1–10.
Farney AC, Sutherland DE, Opara EC. Evolution of islet transplantation for the last 30 years. Pancreas. 2016;45(1):8–20.
Bertuzzi F, Antonioli B, Tosca MC, Galuzzi M, Bonomo M, Marazzi M, Colussi G. Islet transplantation in pediatric patients: current indications and future perspectives. Endocr Dev. 2016;30:14–22.
Greenwald MA, Kuehnert MJ, Fishman JA. Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis. 2012;18(8):e1.
Martinez-Pourcher V. Infections in the transplant patient. Rev Prat. 2015;65(8):1075–8.
Kovacs CS, van Duin D, Guedes de Morais A, Gonzalez BE, Avery RA, Mawhorter SD, Brizendine KD, Cober E, Miranda C, Shrestha RK, Teixeira L, Mossad SB. Selecting suitable solid organ transplant donors: reducing the risk of donor-transmitted infections. World J Transplant. 2014;4(2):43–56.
Johnson CN, Morgan KA, Owczarski SM, Wang H, Fried J, Adams DB. Autotransplantation of culture-positive islet product: is dirty always bad? HPB (Oxford). 2014;16(7):665–9.
Shahrestani S, WA, Lam VW, Yuen L, Ryan B, Pleass HC, Hawthorne WJ. Outcomes from pancreatic transplantation in donation after cardiac death: a systematic review and meta-analysis. Transplantation. 2016; Epub Date 2016/03/08, PMCID: 26950713. doi:10.1097/TP.0000000000001084
Kin T, Rosichuk S, Shapiro AM, Lakey JR. Detection of microbial contamination during human islet isolation. Cell Transplant. 2007;16(1):9–13.
Murray L, McGowan N, Fleming J, Bailey L. Use of the BacT/alert system for rapid detection of microbial contamination in a pilot study using pancreatic islet cell products. J Clin Microbiol. 2014;52(10):3769–71.
Wang Y, Danielson KK, Ropski A, Harvat T, Barbaro B, Paushter D, Qi M, et al. Systematic analysis of donor and isolation factor’s impact on human islet yield and size distribution. Cell Transplant. 2013;22(12):2323–33.
Maffi P, Secchi A. Clinical results of islet transplantation. Pharmacol Res. 2015;98(Aug):86–91.
U.S. Department of Health and Human Services FDA. International standard ISO 14644 and associated controlled environments [Available from: http://drug.fda.moph.go.th/drug/zone_gmp/files/GMP2549_2/Aug2106/7.ISO14644.pdf.
O’Connell PJ, Hawthorne WJ, Holmes-Walker DJ, Nankivell BJ, Gunton JE, Patel AT, et al. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia’s first trial. Med J Aust. 2006;184(5):221–5.
O’Connell PJ, Holmes-Walker DJ, Goodman D, Hawthorne WJ, Loudovaris T, Gunton JE, et al. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(7):1850–8.
Robertson RP. Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care. 2015;38(6):1030–5.
Moassesfar S MU, Frassetto LA, Szot GL, Tavakol M, Stock PG, Posselt AM. A comparative analysis of the safety, efficacy, and cost of islet versus pancreas transplantation in nonuremic patients with type 1 diabetes. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg. 2015.
Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep. 2011;11(5):345–54.
ANZDATA. Australia and New Zealand dialysis and transplant registry 38th report, chapter 2: prevalence of end stage kidney disease. 2016 [Available from: http://www.anzdata.org.au.
Shapiro AM. Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud : RDS. 2012;9(4):385–406.
Beckwith J, Nyman JA, Flanagan B, Schrover R, Schuurman HJ. A health economic analysis of clinical islet transplantation. Clin Transplant. 2012;26(1):23–33.
Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M, et al. Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(11):2595–606.
Owen RJ, Ryan EA, O’Kelly K, Lakey JR, McCarthy MC, Paty BW, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology. 2003;229(1):165–70.
Al-Adra DP, Gill RS, Imes S, O’Gorman D, Kin T, Axford SJ, Shi X, Senior PA, Shapiro AM. Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus. Transplantation. 2014;98(9):1007–12.
Tiwari JL, Schneider B, Barton F, Anderson SA. Islet cell transplantation in type 1 diabetes: an analysis of efficacy outcomes and considerations for trial designs. Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(7):1898–907.
Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, Ho S, Worsley D, Fung M, Meneilly G, Begg I, Al Mehthel M, Kondi J, Harris C, Fensom B, Kozak SE, Tong SO, Trinh M, Warnock G. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011;91(3):373–8.
Chow VC, Pai RP, Chapman JR, O’Connell PJ, Allen RD, Mitchell P, et al. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant. 1999;13(4):356–62.
Usuelli V, La Rocca E. Novel therapeutic approaches for diabetic nephropathy and retinopathy. Pharmacol Res. 2015;98:39–44.
Hays R. Transplant community looks for ways to incentivize living organ donation. Nephrol News Issues. 2016;30(1:24):26–7.
Ponte GM, Pileggi A, Messinger S, Alejandro A, Ichii H, Baidal DA, Khan A, Ricordi C, Goss JA, Alejandro R. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant. 2007;16(6):595–607.
Cravedi P, van der Meer IM, Cattaneo S, Ruggenenti P, Remuzzi G. Successes and disappointments with clinical islet transplantation. Adv Exp Med Biol. 2010;654:749–69.
Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation. 2014;97(3):258–64.
Basta G, Montanucci P, Calafiore R. Islet transplantation versus stem cells for the cell therapy of type 1 diabetes mellitus. Minerva endocrinologica. 2015.
O’Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan EA, et al. The standardization of pancreatic donors for islet isolations. Transplantation. 2005;80(6):801–6.
Lakey JRWG, Rajotte R, Suarez-Aimazor ME, Ao Z, Shapiro AM, Kneteman NM. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation. 1996;61(7):1047–53.
Andres A, Kin T, O’Gorman D, Bigam D, Kneteman N, Senior P, et al. Impact of adverse pancreatic injury at surgical procurement upon islet isolation outcome. Transplant Int : Off J Eur Soc Organ Transplant. 2014;27(11):1135–42.
Pepper AR, Gala-Lopez B, Ziff O, Shapiro AJ. Current status of clinical islet transplantation. World J Transplant. 2013;3(4):48–53.
Cardillo M, Nano R, de Fazio N, Melzi R, Drago F, Mercalli A, et al. The allocation of pancreas allografts on donor age and duration of intensive care unit stay: the experience of the North Italy Transplant program. Transplant Int : Off J Eur Soc Organ Transplant. 2014;27(4):353–61.
Balamurugan AN, Chang Y, Bertera S, Sands A, Shankar V, Trucco M, Bottino R. Suitability of human juvenile pancreatic islets for clinical use. Diabetologia. 2006;49(8):1845–54.
Meier RP, Sert IM P, Muller YD, Borot S, Badet L, Toso C, et al. Islet of Langerhans isolation from pediatric and juvenile donor pancreases. Transpl Int. 2014;27(9):949–55.
Nagaraju S, Bottino R, Wijkstrom M, Trucco M, Cooper DK. Islet xenotransplantation: what is the optimal age of the islet-source pig? Xenotransplantation. 2015;22(1):7–19.
Niclauss N, Bosco D, Morel PD-M S, Brault C, Milliat-Guittard L, Colin C, Parnaud G, et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation. 2011;91(3):360–6.
Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. Jama. 2005;293(7):830–5.
Thwaites SE, Gurung B, Yao J, Kable K, Robertson P, Ryan BJ, Lam VW, Pleass HC, Chapman JR, Hawthorne WJ, Allen RD. Excellent outcomes of simultaneous pancreas kidney transplantation in patients from rural and urban Australia: a national service experience. Transplantation. 2012;94(12):1230–5.
Sakuma Y, Ricordi C, Miki A, Yamamoto T, Pileggi A, Khan A, Alejandro R, et al. Factors that affect human islet isolation. Transplant Proc. 2008;40(2):343–5.
Kaddis JS, Danobeitia JS, Niland JC, Stiller T, Fernandez LA. Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am J Transplant. 2010;10:646–56.
Kuhtreiber WM, Ho LT, Kamireddy A, Yacoub JA, Scharp DW. Islet isolation from human pancreas with extended cold ischemia time. Transplant Proc. 2010;42(6):2027–31.
Lyon J, Manning Fox JE, Spigelman AF, Kim R, Smith N, O’Gorman D, Kin T, Shapiro AM, Rajotte RV, MacDonald PE. Research-focused isolation of human islets from donors with and without diabetes at the Alberta diabetes institute IsletCore. Endocrinology. 2016;157(2):560–9.
Ausania F, Drage M, Manas D, Callaghan CJ. A registry analysis of damage to the deceased donor pancreas during procurement. Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(11):2955–62.
Hameed A, Yu T, Yuen L, Lam V, Ryan B, Allen R, et al. Use of the harmonic scalpel in cold phase recovery of the pancreas for transplantation: the Westmead technique. Transpl Int. 2016.
Romanescu D, Gangone E, Boeti MP, Zamfir R, Dima SO, Popescu I. Technical aspects involved in the harvesting and preservation of the pancreas used for pancreatic islet allotransplantation. Chirurgia (Bucur). 2013;108(3):372–80.
Cao YS, S., Chew HC, Crawford M, Macdonald PS, Laurence J, Hawthorne WJ, et al. Donation after circulatory death for liver transplantation: a meta-analysis on the location of life support withdrawal affecting outcomes. Transplant. 2016.
Dikdan GS, Mora-Esteves C, Koneru B. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation. 2012;94(5):425–41.
Iwanaga YS, Sutherland DE, Harmon JV, Papas KK. Pancreas preservation for pancreas and islet transplantation. Curr Opin Organ Transplant. 2008;13(2):135–41.
Niclauss N, Wojtusciszyn A, Morel P, Demuylder-Mischler S, Brault C, Parnaud G, et al. Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior. Transplantation. 2012;93(7):703–8.
Takita M, Itoh T, Shimoda M, Kanak MA, Shahbazov R, Kunnathodi F, et al. Pancreatic ductal perfusion at organ procurement enhances islet yield in human islet isolation. Pancreas. 2014;43(8):1249–55.
Kuroda YKT, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation. 1988;46:457–60.
Fujino Y. Two-layer cold storage method for pancreas and islet cell transplantation. World J Gastroenterol : WJG. 2010;16(26):3235–8.
Brandhorst H, Asif S, Andersson K, Theisinger B, Andersson HH, Felldin M, Foss A, Salmela K, Tibell A, Tufveson G, Korsgren O, Brandhorst D. A new oxygen carrier for improved long-term storage of human pancreata before islet isolation. Transplantation. 2010;89(2):155–60.
Hosgood SA, Nicholson ML. The role of perfluorocarbon in organ preservation. Transplantation. 2010;89(10):1169–75.
Barlow AD, Hosgood SA, Nicholson ML. Current state of pancreas preservation and implications for DCD pancreas transplantation. Transplantation. 2013;95(12):1419–24.
Li X, Zhang J, Sang L, Chu Z, Dong M. Influence of the two-layer preservation method on human pancreatic islet isolation: a meta-analysis. Int J Artif Organs. 2015;38(3):117–25.
Scott WE, Weegman BP, Ferrer-Fabrega J, Stein SA, Anazawa T, Kirchner VA, et al. Pancreas oxygen persufflation increases ATP levels as shown by nuclear magnetic resonance. Transplant Proc. 2010;42(6):2011–5.
Kim A, Kilimnik G, Guo C, Sung J, Jo J, Periwal V, et al. Computer-assisted large-scale visualization and quantification of pancreatic islet mass, size distribution and architecture. J Visualized Exp: JoVE. 2011(49).
Korsgren O, Nilsson B, Berne C, Felldin M, Foss A, Kallen R, et al. Current status of clinical islet transplantation. Transplantation. 2005;79(10):1289–93.
Wang X, Misawa R, Zielinski MC, Cowen P, Jo J, Periwal V, et al. Regional differences in islet distribution in the human pancreas – preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One. 2013;8(6):e67454.
Ionescu-Tirgoviste C, Gagniuc PA, Gubceac E, Mardare L, Popescu I, Dima S, et al. A 3D map of the islet routes throughout the healthy human pancreas. Sci Rep. 2015;5:14634.
Schaefer JH. The normal weight of the pancreas in the adult human being: a biometric study. Anat Rec. 1926;32(2):119–32.
Caglar V, Kumral B, Uygur R, Alkoc O, Ozen O, Demirel H. Study of volume, weight and size of normal pancreas, spleen and kidney in adults autopsies. Forensic Med Anat Res. 2014;2:63–9.
Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem : Off J Histochem Soc. 2005;53(9):1087–97.
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006;103(7):2334–9.
Eberhard D, Kragl M, Lammert E. ‘Giving and taking’: endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol Metab: TEM. 2010;21(8):457–63.
Otonkoski T, Banerjee M, Korsgren O, Thornell LE, Virtanen I. Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab. 2008;10 Suppl 4:119–27.
Virtanen I, Banerjee M, Palgi J, Korsgren O, Lukinius A, Thornell LE, et al. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia. 2008;51(7):1181–91.
Hughes SJ, Clark A, McShane P, Contractor HH, Gray DW, Johnson PR. Characterisation of collagen VI within the islet-exocrine interface of the human pancreas: implications for clinical islet isolation? Transplantation. 2006;81(3):423–6.
Nanji SA, Shapiro AM. Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab. 2006;8(1):15–25.
Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes : Targets Ther. 2014;7:211–23.
Tuduri E, Bruin JE, Kieffer TJ. Restoring insulin production for type 1 diabetes. J Diabetes. 2012;4(4):319–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hawthorne, W.J. (2016). Necessities for a Clinical Islet Program. In: RamÃrez-DomÃnguez, M. (eds) Pancreatic Islet Isolation. Advances in Experimental Medicine and Biology, vol 938. Springer, Cham. https://doi.org/10.1007/978-3-319-39824-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-39824-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39822-8
Online ISBN: 978-3-319-39824-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)